Skip to content

Evaluation of Fusion After ALIF With an Osteoinductive Material or With Homologus Bone

Evaluation of Fusion After Anterior Lumbar Interbody Fusion With a New Osteoinductive Bone Substitute Material: a First Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03331159
Enrollment
20
Registered
2017-11-06
Start date
2012-07-01
Completion date
2015-10-31
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fusion of Spine, Lumbar Region

Keywords

Lumbar Fusion, Hydroxyapatite

Brief summary

The aim of this study was to determine whether instrumented anterior lumbar interbody Fusion with a new nanocrystalline hydroxyapatite embedded in a silica gel matrix (NH-SiO2) was associated with superior radiological and clinical outcomes at 12 months follow-up compared with instrumented ALIF with homologous bone

Detailed description

This randomized clinical trial included two groups of 20 mature patients with mono- or multisegmental degenerative disease of the lumbar spine who were suitable to undergo mono- or bisegmental ALIF fusion at the level L4/L5 and L5/S1 with a carbon fiber reinforced polymer ALIF cage filled with either NH-SiO2 or homologous bone (HB). Patients were followed 12 months postoperatively. The primary aim was to compare postoperative disability as measured by the Oswestry Disability Index (ODI). Secondary aims were to compare postoperative radiographic outcomes and differences in pain and quality of life between these groups.

Interventions

DEVICENanoBone

Cage was filled with nanocrystalline hydroxyapatite embedded in a silica gel matrix

DEVICEHomologous Bone

Cage was filled with homologous bone

Sponsors

Johann Wolfgang Goethe University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Randomized clinical trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* chronic low back pain * sensorimotor deficits * radiculopathy and spinal claudication symptoms, all caused by degenerative changes in the lumbar spine, which were resistant to conservative pain therapy and / or physiotherapy

Exclusion criteria

* previous surgeries in the abdominal Region * previous fusion surgery in the lumbar spine.

Design outcomes

Primary

MeasureTime frameDescription
Oswestry Disability Index (ODI)12 months after surgeryPostoperative disability as measured by the Oswestry Disability Index (ODI)

Secondary

MeasureTime frameDescription
Fusion rate12 months after surgeryPostoperative radiographic Fusion rate

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026